RFQ
ACU / 001
Precision-led research sourcing

Control the record.
Then source the material.

AcuPep supports qualified B2B research-material inquiries with SKU-level intake, disciplined specification review and batch-document coordination.

Submit technical brief Open registry
White lyophilized research powder in a glass vial
IDSKU-LEVELMODERUO B2B
Registry96product families
Identifiers235controlled SKUs
Protocol03review gates
LocaleENpublished now
Priority registry / 01

Frequently reviewed material records

Each entry exposes the identifiers required to formulate a precise request.

RecordCategoryAvailable contentsAction
01 / BPC-157Research peptides2 mg, 5 mg, 10 mg02 / ARA 290 (Cibinetide)Research peptides10 mg, 15 mg, 16 mg03 / SS-31 / ElamipretideResearch peptides5 mg, 10 mg, 50 mg04 / RetatrutideResearch proteins & analogues2 mg, 5 mg, 10 mg
Evidence protocol / 02

Three gates between a catalog entry and a procurement decision.

Use each evidence layer for the question it is actually capable of answering.

Inspect the full protocol
01

Identifier gate

Product, content, SKU and selected presentation.

02

Applicability gate

Records selected for the material or configuration under review.

03

Release gate

Lot-linked conclusions stay separated from examples and targets.

Example third-party analytical report first pageIllustrative report only
Evidence in context / 03

A sample report is a format preview—not a promise about every lot.

This third-party first-page example demonstrates the type of record a buyer may review. It does not establish accreditation, coverage or results for another material or released lot.

  • Request records against a named SKU
  • Confirm report-to-lot linkage
  • Review stated methods and limitations
Request applicable records
Capability matrix / 04

Declare the program variables before feasibility is inferred.

CAP-01

Identifier control

Resolve product, content and SKU before configuration, evidence or commercial fields enter the request.

CAP-02

Configuration review

Vial, pack, label and project variables are evaluated against the declared scope; no public page represents them as universally available.

CAP-03

Evidence applicability

Requested COA, HPLC, MS, water or microbiological records are checked against the selected configuration or released lot.

CAP-04

Decision trace

Inquiry reference, returned quotation and applicable records form a controlled review path for later revisions.

Inspect capability controls
Intelligence layer / 05

Control notes for technical peptide procurement.

Control note / 6 min

SKU control in peptide procurement

A product name alone is not a controlled request. Content, presentation and identifier must resolve before evidence or quotation comparison.

Analytical note / 8 min

Reading HPLC and MS evidence without over-claiming

Chromatographic purity and observed mass answer specific analytical questions; neither is a universal release statement by itself.

Review protocol / 5 min

Evidence applicability checklist for a released-lot review

A compact gate sequence for deciding whether a document can answer the procurement question in front of the team.

Intake / 06

Lock the identifiers. Declare the evidence. Submit the brief.

Name the material, controlled SKU, quantity, destination and evidence requirements. AcuPep will route the brief for a focused response.

Open technical intake